Cargando…
Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan Parasites
Boron-containing compounds represent a promising class of molecules with proven efficacy against a wide range of pathogens, including apicomplexan parasites. Following lead optimization, the benzoxaborole AN13762 was identified as a preclinical candidate against the human malaria parasite, yet the m...
Autores principales: | Bellini, Valeria, Swale, Christopher, Brenier-Pinchart, Marie-Pierre, Pezier, Tiffany, Georgeault, Sonia, Laurent, Fabrice, Hakimi, Mohamed-Ali, Bougdour, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733022/ https://www.ncbi.nlm.nih.gov/pubmed/33336164 http://dx.doi.org/10.1016/j.isci.2020.101871 |
Ejemplares similares
-
Targeting Toxoplasma gondii
CPSF3 as a new approach to control toxoplasmosis
por: Palencia, Andrés, et al.
Publicado: (2017) -
A brain cyst load-associated antigen is a Toxoplasma gondii biomarker for serodetection of persistent parasites and chronic infection
por: Dard, Céline, et al.
Publicado: (2021) -
Characterization of a Toxoplasma effector uncovers an alternative GSK3/β-catenin-regulatory pathway of inflammation
por: He, Huan, et al.
Publicado: (2018) -
Cinnamoyl-Oxaborole Amides: Synthesis and Their in Vitro Biological Activity
por: Gumbo, Maureen, et al.
Publicado: (2018) -
The Toxoplasma effector TEEGR promotes parasite persistence by modulating NF-kB signalling via EZH2
por: Braun, Laurence, et al.
Publicado: (2019)